LumiraDx Revenue and Competitors

London, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • LumiraDx's estimated annual revenue is currently $347.8M per year.(i)
  • LumiraDx's estimated revenue per employee is $378,000

Employee Data

  • LumiraDx has 920 Employees.(i)
  • LumiraDx grew their employee count by -29% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M5233%N/AN/A
#2
$33.2M12321%N/AN/A
#3
$21.9M81-39%N/AN/A
#4
$37.3M1385%N/AN/A
#5
$25.1M933%N/AN/A
#6
$6.9M32-22%N/AN/A
#7
$210.6M62428%N/AN/A
#8
$69.2M2339%N/AN/A
#9
$23.2M866%N/AN/A
#10
$28.6M106-1%N/AN/A
Add Company

LumiraDx recognizes the need to provide more effective, cost-efficient healthcare for everyone. We make diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences and better value. Founded in 2014 by a group of entrepreneurs with a successful track record of building and scaling diagnostics and health IT businesses, LumiraDx is now expanding the number of representatives and subsidiaries in all continents.

keywords:N/A

N/A

Total Funding

920

Number of Employees

$347.8M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LumiraDx News

2022-04-20 - LumiraDx (NASDAQ:LMDX) Downgraded to Sell at Zacks ...

LumiraDx (NASDAQ:LMDX) Downgraded to Sell at Zacks Investment Research. Posted by admin on Apr 28th, 2022. Share on Twitter Share on Facebook Share on...

2022-04-13 - LumiraDx Limited (NASDAQ:LMDX) Sees Significant ...

LumiraDx Limited (NASDAQ:LMDX) Sees Significant Decrease in Short Interest. Posted by admin on Apr 19th, 2022. Share on Twitter Share on Facebook Share on...

2022-03-22 - LumiraDx Reports Fourth Quarter and Full Year 2021 Results

LumiraDx (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014,...

2019-09-07 - HiSTORIC Validates High-Sensitivity Troponin Test to Rule ...

Mills has acted as a consultant for Abbott Diagnostics, Siemens Healthineers, and LumiraDx; his institution has received grants from Abbott ...

2019-08-31 - Rapid pathway for suspected heart attack enables healthy ...

... outside the submitted work, and honoraria from Abbott Diagnostics, Siemens Healthineers, Roche Diagnostics, Singulex and LumiraDx.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$373.5M920N/AN/A
#2
$206.5M9224%N/A
#3
$348.5M92211%N/A
#4
$348.9M92317%N/A
#5
$207M9242%N/A

LumiraDx Executives


NameTitle
Steve McRobertsChief Risk Officer (Technical)
David WaltonChief Commercial Officer
Nigel LindnerChief Innovation Officer
Ron ZwanzigerCEO/Chairman/Director
Jerry McAleerChief Scientist/Director
David ScottCTO/Director
Dorian LeBlancChief Financial Officer
Yvonne HarrisonCartoning tecnicion
Carlos ArmandoChief Financial Officer
Diana CatalanoVice President Legal, North America
Pooja PathakVP Platform Strategy
Todd StorchVice President Of Engineering
Steven SepulvedaVice President Of Corporate Accounts
Leonard WayVice President Operations (Fast Lab)
Giffin DaughtridgeVP/GM
Veronique AmeyeExecutive Vice President & General Counsel
David LangSenior Vice President Strip Manufacturing & Innovation
Kevin CunninghamVP / GM
Deborah HolmesVP Talent Management
Per GrufmanVP of R&D
Timothy BlicharzVice President, Quality & Regulatory Affairs, North America
Peter ScheuPresident, North American Commercial Operations
Peter WelchVP Business Development